What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Rickettsia rickettsii and Rocky Mountain Spotted Fever in Dogs: Clinical Manifestations and Diagnostic Approaches

Introduction

Rocky Mountain spotted fever (RMSF) is a severe, acute tick-borne zoonosis caused by the obligate intracellular Gram-negative bacterium Rickettsia rickettsii. In dogs, the disease produces a constellation of clinical signs ranging from subclinical infection to fulminant systemic illness with high fatality if untreated [1, 48]. Domestic dogs serve not only as sentinel hosts for human disease risk but also as amplifying hosts for certain tick vectors, thereby playing a critical role in the enzootic maintenance of R. rickettsii in endemic foci [15, 39]. This review provides a clinical and diagnostic reference for veterinary practitioners and diagnosticians, focusing on the molecular and cellular basis of pathogenesis, clinical presentation in dogs, and the suite of diagnostic modalities available for confirming infection.

Rickettsia rickettsii: Etiology and Pathogen Biology

Rickettsia rickettsii belongs to the spotted fever group (SFG) of the family Rickettsiaceae. It is an obligate intracellular bacterium that targets primarily microvascular endothelial cells in mammalian hosts. The bacterium possesses a small genome (approximately 1.25 Mb) that reflects its reliance on host cell metabolic machinery [1]. The organism induces its own uptake into non-phagocytic host cells via a zipper-like mechanism and rapidly escapes the phagosome to replicate freely within the host cytosol.

Virulence determinants have been characterized in recent years. The type IV secretion system (T4SS) delivers effector proteins into the host cell. Among these, Rickettsial Ankyrin Repeat Protein 2 (RARP2) is a clan CD cysteine protease that selectively fragments the trans-Golgi network without disrupting the cis-Golgi, thereby impairing anterograde protein trafficking and reducing interferon-beta secretion [2, 16]. The autotransporter peptidase RapL proteolytically processes surface-exposed autotransporters and enhances intracellular survival by suppressing host cell lysis and interferon-beta production [2, 3]. A negative regulator of actin-based motility, regulator of actin-based motility (RoaM), has been identified; disruption of RoaM increases actin tail formation but does not enhance virulence in guinea pigs, suggesting a tightly regulated motility system [4]. The bacterium also encodes Sca2, which directly nucleates actin polymerization, enabling cell-to-cell spread [4].

R. rickettsii exhibits isolate-dependent virulence. Whole genome sequence analysis and phenotypic characterization have enabled classification of isolates into nonvirulent (Iowa), mildly virulent (Sawtooth, Gila), and highly virulent (Sheila Smith, Costa Rica, Taiaçu) categories [21]. Transcriptional profiling of virulence factors correlates with these phenotypic differences [21]. A novel subspecies, R. rickettsii subsp. californica (formerly R. philipii or strain 364-D), has been proposed as the etiologic agent of Pacific Coast tick fever, a moderate spotted fever illness [5].

Epidemiology and Vector Ecology

Primary Tick Vectors

R. rickettsii is transmitted transstadially and transovarially within tick populations. The primary vectors vary by geographic region. In the United States, the American dog tick (Dermacentor variabilis) and the Rocky Mountain wood tick (Dermacentor andersoni) are the principal vectors [28]. The brown dog tick (Rhipicephalus sanguineus sensu lato) has been implicated in urban and peridomestic transmission cycles in parts of the southwestern United States, Mexico, and Panama [42]. In Brazil, Amblyomma sculptum (formerly part of the Amblyomma cajennense species complex) and Amblyomma aureolatum are the primary vectors [6, 15, 29, 32]. The invasive Asian longhorned tick (Haemaphysalis longicornis) has been demonstrated to acquire and transmit R. rickettsii under laboratory conditions, although its role in natural transmission cycles remains uncertain [7]. The lone star tick (Amblyomma americanum) is also competent under laboratory conditions [35].

Vector Competence and Tick Population Susceptibility

Vector competence varies among tick species and populations. A. aureolatum is more susceptible to R. rickettsii infection than A. sculptum, a difference that correlates with distinct transcriptional responses in the midgut [25, 32]. Populations of A. sculptum exposed to autochthone strains of R. rickettsii show higher susceptibility and transovarial transmission rates compared to populations exposed to non-autochthone strains [29]. Infection induces mortality in engorged larvae and nymphs and reduces reproductive fitness in females, which explains the typically low natural infection rates (below 1%) in A. sculptum populations [27, 29].

Amplifying Hosts

Horizontal transmission via rickettsemic amplifying hosts is essential for the maintenance of R. rickettsii in nature. Capybaras (Hydrochoerus hydrochaeris) are critical amplifying hosts for A. sculptum in Brazil. During primary infection, capybaras develop rickettsemia lasting a mean of 9.2 days, during which feeding ticks acquire the pathogen. Subsequent exposures in immune capybaras do not result in rickettsemia [18, 26]. Domestic dogs also act as amplifying hosts for A. aureolatum in the Sao Paulo metropolitan area. Infected dogs develop illness, seroconvert, and transmit R. rickettsii to feeding ticks, with transovarial transmission rates estimated at 25% [15]. Mathematical models demonstrate that capybara birth rate and mobility significantly influence disease propagation and that interventions reducing capybara birth rate by more than 58% can prevent the establishment of new endemic foci [37, 46].

Tick Reactivation and Transmission Dynamics

Contrary to earlier hypotheses, R. rickettsii residing in salivary glands of unfed questing ticks does not require a period of reactivation. Ticks can transmit infectious rickettsiae virtually as soon as they attach to the host, with attachments of less than 10 hours resulting in clinically identifiable infection in guinea pigs [28]. Co-feeding nonsystemic transmission (transmission between infected and uninfected ticks feeding on immune hosts without systemic infection) is negligible for A. aureolatum and A. sculptum [18, 47].

Clinical Manifestations in Dogs

Rickettsia rickettsii Rocky Mountain Spotted Fever Dogs Clinical

The incubation period in dogs ranges from 2 to 14 days following tick attachment. Clinical signs are variable and often nonspecific, which contributes to diagnostic challenges. The classic triad of fever, petechiation, and neurologic signs is not always present, particularly in early stages.

Fever. Acute onset of high fever (39.5 to 41.5 degrees Celsius) is the most consistent finding. Fever may be biphasic in some cases.

Vasculitis and Hemostatic Abnormalities. The hallmark pathologic process is extensive endothelial cell infection leading to systemic vasculitis. This results in petechial and ecchymotic hemorrhages on mucous membranes, the skin (particularly the ears, scrotum, and oral mucosa), and internal organs. Thrombocytopenia, often moderate to severe, occurs in a majority of cases due to platelet consumption at sites of endothelial injury and immune-mediated destruction. Coagulation abnormalities including prolonged activated partial thromboplastin time and prothrombin time may be observed in severe cases [14].

Neurologic Signs. Central nervous system involvement occurs in approximately 30% of severely affected dogs. Signs include depression, ataxia, vestibular dysfunction, seizures, hyperesthesia, and coma. Neurologic deficits result from direct rickettsial infection of cerebral microvascular endothelium leading to perivascular edema, hemorrhage, and inflammation.

Ocular and Mucocutaneous Signs. Conjunctivitis, scleral injection, uveitis, and retinal hemorrhages may be observed. Petechiae on the oral mucosa, scrotum, and pinnae are common.

Gastrointestinal and Renal Signs. Vomiting, diarrhea, and abdominal pain are reported. Acute kidney injury due to renal vasculitis may occur.

Coinfection. Dogs may be coinfected with other tick-borne pathogens including Ehrlichia canis and Bartonella species. Coinfection can exacerbate clinical signs and complicate diagnosis [14, 34]. A study in pediatric patients coinfected with R. rickettsii and E. canis showed elevated liver enzymes, prolonged coagulation times, leukocytosis, neutrophilia, thrombocytopenia, lymphopenia, and hypoalbuminemia [14].

Pathogenesis and Host-Pathogen Interactions

Endothelial Cell Infection and Innate Immune Evasion

R. rickettsii productively replicates in human dermal microvascular endothelial cells (HDMECs). The virulent Sheila Smith strain demonstrates robust replication, while the attenuated Iowa strain shows minimal replication and non-pathogenic R. montanensis loses viability, inducing rapid programmed cell death [2]. The virulent strain suppresses interferon-beta secretion through the actions of RARP2 and RapL. RARP2 disrupts the trans-Golgi network and inhibits anterograde trafficking, while RapL restores autotransporter processing and further suppresses interferon-beta production and host cell lysis [2, 16].

Apoptosis Inhibition in Tick Cells

In tick cells, R. rickettsii exerts an inhibitory effect on apoptosis. Infection modulates the tick cell proteome, downregulating negative regulators of apoptosis in the initial phase and upregulating them during exponential bacterial growth. Caspase-3 activity and phosphatidylserine exposure are reduced in infected cells, and DNA fragmentation is observed only in non-infected cells. Chemical activation of caspase-3 reduces rickettsial proliferation, while inhibition increases bacterial growth [24].

Nitric Oxide and Antimicrobial Activity

Nitric oxide (NO) synthesized by inducible nitric oxide synthase (iNOS) is a potent antirickettsial effector. NO disrupts bacterial energetics, reduces adhesion, and inhibits protein synthesis and replication. Activated NO-producing macrophages restrict R. rickettsii infection, and inhibition of iNOS abrogates this restriction [20].

MicroRNA-Mediated Regulation

Host microRNA miR-424-5p is robustly downregulated during R. rickettsii infection of HDMECs. This downregulation leads to increased expression of CX3CL1 (fractalkine), a bifunctional chemokine and adhesion molecule that contributes to immune cell recruitment at sites of infection. MiR-424 mimic downregulates CX3CL1 expression, while miR-424 inhibitor upregulates it, demonstrating a regulatory axis [22].

Diagnostic Approaches

Serology

Indirect Immunofluorescence Assay (IFA). The reference standard for serologic diagnosis is IFA using R. rickettsii antigen. A fourfold rise in IgG or IgM titers between acute and convalescent sera (collected 2 to 4 weeks apart) is considered diagnostic. A single titer of 1:64 or higher is considered seropositive but may reflect past exposure rather than acute infection [40]. Cross-reactivity among SFG rickettsiae is extensive; IFA cannot reliably differentiate between species.

Enzyme-Linked Immunosorbent Assay (ELISA). Commercial ELISA kits for detection of antibodies to SFG rickettsiae are available for canine use. Performance characteristics (sensitivity and specificity) vary between kits and must be validated against IFA and clinical gold standards as described for Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus p27 antigen detection.

Molecular Diagnostics

Conventional and Real-Time Polymerase Chain Reaction (PCR). PCR targeting the gltA (citrate synthase), ompA (190-kDa outer membrane protein A), or ompB (135-kDa outer membrane protein B) genes is widely used. Whole blood (EDTA), skin biopsy from rash sites, and tissues (spleen, lung, liver) are suitable specimens. PCR is most sensitive during the acute febrile phase before antibiotic therapy. Sensitivity diminishes rapidly after initiation of doxycycline.

Loop-Mediated Isothermal Amplification (LAMP). A LAMP assay targeting a putative R. rickettsii gene has been developed and validated. The assay uses three pairs of primers and hydroxy naphthol blue (HNB) as a colorimetric indicator of magnesium pyrophosphate formation. Analytical sensitivity is approximately 1.6 to 3 pg of DNA, which is 10 times more sensitive than conventional PCR. For human samples, clinical sensitivity was 93% (HNB readout) and 97% (electrophoresis readout) with specificities of 70% and 58% respectively. For tick samples, sensitivity was 80% (HNB) and 87% (electrophoresis) with specificity of 93% and 87% respectively. Results are obtained within 60 minutes without the need for thermocyclers [8].

Recombinase Polymerase Amplification with Lateral Flow (RPA-LF). An RPA-LF assay targeting R. rickettsii has been developed with a limit of detection of 10 to 50 copies per reaction. The assay achieves analytical sensitivity of at least 90% and specificity of 100% with no cross-reactivity to other organisms. Results are obtained within 30 minutes using only a constant temperature source, making it suitable for field deployment [50].

Immunohistochemistry (IHC)

IHC on formalin-fixed, paraffin-embedded tissues (skin biopsy, spleen, lung, brain) using monoclonal antibodies against SFG rickettsial antigens is a definitive diagnostic method available through reference laboratories. IHC is especially valuable for postmortem confirmation.

Hematologic and Biochemical Abnormalities

Hematologic findings include thrombocytopenia, leukocytosis with neutrophilia, lymphopenia, and normocytic normochromic anemia. Biochemical abnormalities commonly include elevated liver enzymes (alanine aminotransferase, aspartate aminotransferase), hypoalbuminemia, prolonged coagulation times (prothrombin time, activated partial thromboplastin time), and elevated creatine kinase [14].

Diagnostic Decision Tree

graph TD
    A[Canine patient with fever, tick exposure history], > B{Clinical suspicion of RMSF}
    B, > C[Collect EDTA whole blood and serum]
    C, > D{Rickettsia rickettsii PCR}
    D, >|Positive| E[Confirmed acute infection; initiate doxycycline]
    D, >|Negative| F{Acute and convalescent IFA}
    F, >|Fourfold titer rise| E
    F, >|Single titer &lt;1:64| G[RMSF unlikely; consider differentials]
    F, >|Single titer &gt;=1:64| H[Possible past exposure or early infection; repeat serology]
    B, > I[Consider skin biopsy for PCR or IHC if rash present]
    I, >|Positive| E
    I, >|Negative| F

Treatment and Management

Doxycycline

Doxycycline is the antimicrobial of choice for RMSF in dogs. The recommended dosage is 5 mg/kg orally every 12 hours or 10 mg/kg orally every 24 hours for a minimum of 14 days. For severely ill dogs unable to tolerate oral medication, intravenous doxycycline may be administered. Treatment should be initiated immediately upon clinical suspicion; delays are associated with increased morbidity and mortality.

Tigecycline

Tigecycline, a glycylcycline antibiotic, has demonstrated efficacy against R. rickettsii in vitro and in vivo. In a guinea pig model, subcutaneous tigecycline (3.75 mg/kg every 12 hours) resulted in undetectable or reduced bacterial loads in liver, lung, spleen, skin, and testes compared to untreated animals, with efficacy comparable to doxycycline (5 mg/kg subcutaneously every 12 hours) [41]. Tigecycline represents a potential alternative when intravenous doxycycline is unavailable.

Supportive Care

Aggressive fluid therapy is indicated for dehydrated or hypotensive patients. Blood product transfusion may be required for severe thrombocytopenia or hemorrhage. Anticonvulsant therapy should be administered to patients with seizures. Nonsteroidal anti-inflammatory drugs are contraindicated due to the risk of exacerbating vasculitis and renal injury.

Prognosis

With prompt doxycycline therapy, the prognosis for recovery is good. Mortality rates in treated dogs are low. Delayed treatment, severe neurologic involvement, disseminated intravascular coagulation, or coinfection with other pathogens worsens the prognosis.

Zoonotic Considerations

RMSF is a serious zoonotic disease. Dogs serve as sentinels for human risk because they share the same tick vector habitat. Veterinary personnel should use appropriate barrier precautions when handling blood and tissues from suspect cases. Owners should be educated about tick prevention on pets and in the environment. Human cases of RMSF can be severe and fatal if not recognized and treated early. The case fatality rate in untreated humans ranges from 20% to 30% [1, 48]. Outbreaks in families have been reported, with attack rates affecting multiple members simultaneously [9, 19].

Vaccination

No licensed vaccine for RMSF exists for dogs or humans. Experimental whole-cell inactivated antigen (WCA) vaccine has shown protective efficacy in a canine model. Dogs vaccinated with WCA were protected from clinical disease upon challenge, with pathogen loads reduced to nearly undetectable levels in blood, lungs, liver, spleen, and brain [39]. Subunit vaccines containing recombinant outer membrane proteins (RCA) were not protective [39]. Reverse vaccinology approaches have identified four antigenic, non-allergenic proteins suitable for chimeric vaccine design, and computational analyses (molecular docking, molecular dynamics simulations, MM-GBSA binding free energy) predict strong immunogenic potential [1]. Th1 epitope peptides have also been shown to induce protective immunity in mouse models [49].

Conclusion

Rickettsia rickettsii infection in dogs presents a diagnostic and therapeutic challenge due to its nonspecific clinical signs and the potential for rapid progression. Understanding the molecular mechanisms of endothelial cell infection and immune evasion informs the clinical approach. A combination of serology, PCR-based molecular assays (conventional, LAMP, RPA-LF), and immunohistochemistry provides a robust diagnostic framework. Early treatment with doxycycline is critical for favorable outcomes. Dogs play a central role both as sentinels for human disease and as amplifying hosts for tick vectors, underscoring the importance of a One Health approach to RMSF surveillance and prevention.

References

[1] Arshad F, Sarfraz A, Shehroz M, et al. Core-genome guided novel therapeutic targets identification and chimeric vaccine designing against Rickettsia rickettsii. Scientific Reports. 2025. URL: https://www.semanticscholar.org/paper/e90c30f3ffa108f668111f19a3a602e62151458e

[2] Fitzsimmons LF, Bublitz D, Clark T, et al. Rickettsia rickettsii virulence determinants RARP2 and RapL mitigate IFN-beta signaling in primary human dermal microvascular endothelial cells. mBio. 2024. URL: https://www.semanticscholar.org/paper/9aa5a86596fbcce91c1918720ed4b8861da63f9d

[3] Nock A, Aistleitner K, Clark T, et al. Identification of an autotransporter peptidase of Rickettsia rickettsii responsible for maturation of surface exposed autotransporters. PLoS Pathogens. 2023. URL: https://www.semanticscholar.org/paper/96dc32a88c8722a9b8a310a26090b4e2625e3c67

[4] Nock A, Clark T, Hackstadt T. Regulator of Actin-Based Motility (RoaM) Downregulates Actin Tail Formation by Rickettsia rickettsii and Is Negatively Selected in Mammalian Cell Culture. mBio. 2022. URL: https://www.semanticscholar.org/paper/c7b6dda223f750ee607e571f3ae968b178c430f7

[5] Paddock CD, Karpathy SE, Henry A, et al. Rickettsia rickettsii subsp. californica subsp. nov., the etiologic agent of Pacific Coast tick fever. Journal of Infectious Diseases. 2024. URL: https://www.semanticscholar.org/paper/b447cb259dd0b534014ca92803076708150236cb

[6] Cardoso ERN, Carvalho SF, Dias SA, et al. Susceptibility of Amblyomma sculptum, Vector of Rickettsia rickettsii, Ticks from a National Park and an Experimental Farm to Different Synthetic Acaricides. Pathogens. 2023. URL: https://www.semanticscholar.org/paper/362b27586b335d8a2a7e8ad276df22d376b425c8

[7] Stanley HM, Ford SL, Snellgrove AN, et al. The Ability of the Invasive Asian Longhorned Tick Haemaphysalis longicornis to Acquire and Transmit Rickettsia rickettsii, the Agent of Rocky Mountain Spotted Fever, Under Laboratory Conditions. Journal of Medical Entomology. 2020. URL: https://www.semanticscholar.org/paper/2c8fc9ef0ca3d4a35427c6ddb8a36303ffda0372

[8] Carvajal-Gamez BI, Olguin-Barrera A, Tinoco-Gracia L, et al. Development and validation of a novel detection method for Rickettsia rickettsii using a loop-mediated isothermal amplification assay. Frontiers in Microbiology. 2024. URL: https://www.semanticscholar.org/paper/20179873a78f4a4ccdaa1389f300cc29c7d6b84e

[9] Daza T C, Estripeaut D, Santana Morales M, et al. Clinical manifestations of Rickettsia rickettsii in a familial outbreak in Panama. Travel Medicine and Infectious Disease. 2023. URL: https://www.semanticscholar.org/paper/6698f2c5f84cdc7a6c274a9a92417140c8a496bb

[10] Binder LC, Fanchini CEC, Soares HS, et al. Vector competence and transovarial transmission of Rickettsia rickettsii in Rickettsia bellii-infected and -uninfected Amblyomma dubitatum ticks. Experimental & Applied Acarology. 2025. URL: https://www.semanticscholar.org/paper/679ca8d6048c86b94e085c948a625a0679e6360a

[11] Nock A, Clark T, Hackstadt T. Development of inducible promoter and CRISPRi plasmids functional in Rickettsia rickettsii. bioRxiv. 2024. URL: https://www.semanticscholar.org/paper/e1c3120109696e09e697c63bac4155acbc65c9b0

[12] Ribeiro C, de Carvalho JLB, Bastos PAS, et al. Prevalence of Rickettsia rickettsii in Ticks: Systematic Review and Meta-Analysis. Vector Borne and Zoonotic Diseases. 2021. URL: https://www.semanticscholar.org/paper/1e6f0544fefd073b7fd7d5ecc4cc70402d5103b2

[13] Crandall KE, Kerr J, Millien V. Emerging Tick-Borne Pathogens in Central Canada: Recent Detections of Babesia odocoilei and Rickettsia rickettsii. Vector Borne and Zoonotic Diseases. 2022. URL: https://www.semanticscholar.org/paper/072e536530838